NOBIVAC® Edge DAPPv+L4
NOBIVAC EDGE DAPPv+L4 provides proven protection against several common viruses and enhanced quality in leptospirosis protection.
LEARN MOREGilvetmab
Gilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MORENOBIVAC EDGE® DAPPv
Approved for protection of healthy dogs against canine distemper, adenovirus (Type 1), CPIV and CPV.
LEARN MOREREVALOR®-G
REVALOR® -G is used in more stocker cattle than any other brand. In fact, it leads the next closest implant brand by a more than 2-to-1 margin.
LEARN MOREREVALOR®-200
As part of an aggressive implant strategy, REVALOR® -200 increases rate of gain and improves feed efficacy in feedlot cattle.
LEARN MOREBOSS® POUR-ON INSECTICIDE
For fly control for lactating and non-lactating dairy cattle and beef cattle and calves, and ked and lice control on sheep.
LEARN MORECORVAC-3®
For the vaccination of healthy chickens against disease caused by Avibacterium paragallinarum (CORYZA).
LEARN MORENobivac® Puppy-DPv
For the vaccination of healthy puppies for the prevention of disease caused by canine distemper virus and CPV.
LEARN MORENobivac® NXT FeLV
First and only non-adjuvanted feline leukemia virus (FeLV) vaccine built on RNA particle technology
LEARN MORENobivac® NXT Canine Flu H3N2
First and only canine flu vaccine built on RNA particle technology
LEARN MORENOBIVAC® Lyme Vaccine
For vaccination of healthy dogs 8 weeks or older against Borrelia burgdorferi. Duration of Immunity is at least 1 year.
LEARN MORENOBIVAC® Lepto₄ Vaccine
For vaccination of healthy dogs against Leptospira canicola, L. icterohaemorrhagiae, L. pomona and L. grippotyphosa.
LEARN MORE
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global